|
|
|
Insider
Information: |
Baynes Roy D. |
Relationship: |
|
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
90,183 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$2,741,790 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
90,183 |
|
|
Total
Value |
$2,741,790 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Travere Therapeutics, Inc |
TVTX |
|
2024-05-08 |
31,000 |
2016-07-19 |
0 |
Premium* |
|
Atara Biotherapeutics, Inc. |
ATRA |
|
2022-06-23 |
43,500 |
2019-06-27 |
0 |
Premium* |
|
Natera, Inc. |
NTRA |
|
2024-07-26 |
15,683 |
2020-08-07 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
29 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
TVTX |
Travere Therapeutics, Inc |
Director |
|
2016-07-19 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
4,000 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2017-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
6,500 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2018-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
9,000 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2019-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
11,000 |
0 |
- |
|
ATRA |
Atara Biotherapeutics, In... |
Director |
|
2019-06-27 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
4,000 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2020-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
14,000 |
0 |
- |
|
ATRA |
Atara Biotherapeutics, In... |
Director |
|
2020-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
12,000 |
0 |
- |
|
NTRA |
Natera, Inc. |
Director |
|
2020-08-07 |
4 |
S |
$53.47 |
$69,513 |
D/D |
(1,300) |
0 |
0 |
- |
|
NTRA |
Natera, Inc. |
Director |
|
2020-08-07 |
4 |
OE |
$24.42 |
$31,746 |
D/D |
1,300 |
1,300 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2021-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
17,000 |
0 |
- |
|
NTRA |
Natera, Inc. |
|
|
2021-05-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,856 |
2,856 |
0 |
- |
|
ATRA |
Atara Biotherapeutics, In... |
|
|
2021-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
11,000 |
23,000 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2022-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
20,000 |
0 |
- |
|
NTRA |
Natera, Inc. |
|
|
2022-05-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,307 |
4,163 |
0 |
- |
|
ATRA |
Atara Biotherapeutics, In... |
|
|
2022-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
20,500 |
43,500 |
0 |
- |
|
NTRA |
Natera, Inc. |
|
|
2022-07-08 |
4/A |
A |
$0.00 |
$0 |
D/D |
344 |
4,507 |
0 |
- |
|
NTRA |
Natera, Inc. |
|
|
2022-10-14 |
4 |
A |
$45.42 |
$12,491 |
D/D |
275 |
4,782 |
0 |
- |
|
NTRA |
Natera, Inc. |
|
|
2023-01-13 |
4 |
A |
$40.01 |
$12,483 |
D/D |
312 |
5,094 |
0 |
- |
|
NTRA |
Natera, Inc. |
|
|
2023-04-14 |
4 |
A |
$54.73 |
$12,478 |
D/D |
228 |
5,322 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2023-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
24,500 |
0 |
- |
|
NTRA |
Natera, Inc. |
|
|
2023-05-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,534 |
8,856 |
0 |
- |
|
NTRA |
Natera, Inc. |
|
|
2023-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
2,750 |
11,606 |
0 |
- |
|
NTRA |
Natera, Inc. |
|
|
2023-07-28 |
4 |
A |
$48.48 |
$12,799 |
D/D |
264 |
11,870 |
0 |
- |
|
NTRA |
Natera, Inc. |
|
|
2023-10-27 |
4 |
A |
$42.60 |
$13,717 |
D/D |
322 |
12,192 |
0 |
- |
|
NTRA |
Natera, Inc. |
|
|
2024-01-26 |
4 |
A |
$63.79 |
$13,715 |
D/D |
215 |
12,407 |
0 |
- |
|
29 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|